SG Americas Securities’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
SG Americas Securities's NEO Position: Q2 2026 in Review
SG Americas Securities reduced its NeoGenomics (NEO) stake by 1.4% in Q2 2026, selling an estimated $42.8K and leaving 307,721 shares worth $4.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1141.
SG Americas Securities first reported a position in NEO in Q4 2018 and has held it in 27 quarters since. The position peaked at $10.3M in Q3 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- SG Americas Securities held 307,721 shares of NeoGenomics worth $4.49M as of Q2 2026.
- SG Americas Securities sold 4,433 NeoGenomics shares in Q2 2026, an estimated $42.8K.
- NeoGenomics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1141 holding.
- SG Americas Securities first reported a position in NeoGenomics in Q4 2018 and has held it in 27 quarters since.
- SG Americas Securities's NeoGenomics position peaked at $10.3M in Q3 2021.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.